Backgound&aims: The Baveno VII consensus introduced the term "recompensated cirrhosis," though few studies have examined its clinical relevance. We analyzed the rate and predictors of recompensation in hepatitis C (HCV) patients after sustained virological response (SVR) and evaluated its impact on mortality and hepatocellular carcinoma (HCC) compared to compensated and decompensated cirrhosis.
Methods: Multicenter observational study enrolling 916 HCV-related cirrhotic patients, with a minimum follow-up period of 12 months after SVR.